Work

Sodium-glucose co-transporter 2 inhibition and acute myocardial infarction: the DAPA-MI and EMPACT-MI trials

Year: 2024

Type: editorial

Abstract: 1. Ischemic heart disease, the leading cause of global mortality according to the World Health Organization, claims roughly 16% of lives worldwide [1]. In the United States alone, cardiovascular di...

Source: Expert Review of Clinical Pharmacology

DOI: 10.1080/17512433.2024.2390921

Authors: Muhammad Adnan Zaman, Sidra Kalsoom

Institutions: Conemaugh Health System, Mercy St. Vincent Medical Center, Mercy Health

Language: English

Topic: Diabetes Treatment and Management

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4401430274

Cites: 29

Cited by: 5

Related to: 10